Search
Pooja Sodha, MD, assistant professor of dermatology, spoke to Today.com about whether LED masks are effective against acne and wrinkles.
Victoria Shanmugam, MD, director of the Division of Rheumatology and professor of medicine, spoke to Tegna Broadcasting for a segment on whether COVID-19 vaccines are as effective for immunocompromised people.
Marie Borum, MD, director of the Division of Gastroenterology and professor of medicine, spoke to The Washington Post about perforated ulcers, what causes them, and how they are treated.
Adam Friedman, MD, chair of the Department of Dermatology and professor of dermatology, spoke to Reuters for an article about claims that sunscreen is not safe.
Katherine Chiappinelli, PhD, assistant professor of microbiology, immunology, and tropical medicine at the George Washington University School of Medicine and Health Sciences, received a $1.87 million grant from the National Institutes of Health to research the regulation of repetitive elements in…
The Washington Business Journal interviewed Adam Friedman, MD, professor and chair of the Department of Dermatology for their Executive Profile series.
Tailoring specific learning methods to varying learning approaches may contribute to improved leadership competencies, according to a study conducted by five researchers from the George Washington University School of Medicine and Health Sciences.
Nanotechnology delivery systems may be an innovative and effective approach to delivering cannabinoids for skin care, according to a team from the Department of Dermatology at the George Washington University School of Medicine and Health Sciences.
With a five-year, $2.17 million grant from the National Institutes of Health, Wenge Zhu, PhD, associate professor of biochemistry and molecular medicine at the George Washington University School of Medicine and Health Sciences, is aiming to help ovarian cancer patients overcome resistance to…
A team of researchers from the George Washington University (GW) has been selected as one of five sites participating in the HIV Prevention Trials Network (HPTN) INTEGRA study (HPTN 094).